0 CHECKOUT

Traumatic Brain Injury - Pipeline Review, H2 2015

  • ID: 3492388
  • September 2015
  • 267 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • ALSP, Inc.
  • Cognosci, Inc.
  • Ischemix
  • Mapreg S.A.S.
  • Neuronax SAS
  • Phylogica Limited
  • MORE

Traumatic Brain Injury - Pipeline Review, H2 2015

Summary

The report ‘Traumatic Brain Injury - Pipeline Review, H2 2015’, provides an overview of the Traumatic Brain Injury’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Traumatic Brain Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Traumatic Brain Injury and special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updates following a stringent READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • ALSP, Inc.
  • Cognosci, Inc.
  • Ischemix
  • Mapreg S.A.S.
  • Neuronax SAS
  • Phylogica Limited
  • MORE

List of Tables

List of Figures

Introduction

REPORT COVERAGE

Traumatic Brain Injury Overview

Therapeutics Development

Pipeline Products for Traumatic Brain Injury - Overview

Pipeline Products for Traumatic Brain Injury - Comparative Analysis

Traumatic Brain Injury - Therapeutics under Development by Companies

Traumatic Brain Injury - Therapeutics under Investigation by Universities/Institutes

Traumatic Brain Injury - Pipeline Products Glance

Late Stage Products

Clinical Stage Products

Early Stage Products

Unknown Stage Products

Traumatic Brain Injury - Products under Development by Companies

Traumatic Brain Injury - Products under Investigation by Universities/Institutes

Traumatic Brain Injury - Companies Involved in Therapeutics Development

Adamas Pharmaceuticals, Inc.

ALSP, Inc.

Amarantus Bioscience Holdings, Inc.

Athersys, Inc.

BHR Pharma, LLC

Cognosci, Inc.

Euroscreen S.A.

Grupo Ferrer Internacional, S.A.

International Stem Cell Corporation

Io Therapeutics, Inc.

Ischemix

Karyopharm Therapeutics, Inc.

Kyorin Pharmaceutical Co., Ltd.

Levolta Pharmaceuticals, Inc.

Lixte Biotechnology Holdings, Inc.

Lpath, Inc.

MandalMed, Inc.

Mapreg S.A.S.

Mnemosyne Pharmaceuticals, Inc.

Neuralstem, Inc.

Neuren Pharmaceuticals Limited

NeuroHealing Pharmaceuticals Inc.

NeuroNascent, Inc.

Neuronax SAS

NeuroVive Pharmaceutical AB

Omeros Corporation

PharmatrophiX, Inc.

Phylogica Limited

Prevacus, Inc.

PsychoGenics, Inc.

QR Pharma, Inc.

RAPID Pharmaceuticals AG

RegeneRx Biopharmaceuticals, Inc.

Remedy Pharmaceuticals, Inc.

Sage Therapeutics

SanBio, Inc.

STATegics, Inc.

Tetra Discovery Partners LLC

VG Life Sciences, Inc.

Traumatic Brain Injury - Therapeutics Assessment

Assessment by Monotherapy Products

Assessment by Combination Products

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Drug Profiles

2-DG - Drug Profile

ALP-496 - Drug Profile

amantadine hydrochloride ER - Drug Profile

AMRS-001 - Drug Profile

apomorphine hydrochloride - Drug Profile

AST-002 - Drug Profile

AVL-8168 - Drug Profile

Cell Therapy to Activate hNT-3 for Spinal Cord and Traumatic Brain Injury - Drug Profile

CHEC-7 - Drug Profile

CHEC-9 - Drug Profile

CMX-2043 - Drug Profile

CNB-001 - Drug Profile

COG-1410 - Drug Profile

cyclosporine - Drug Profile

dexamethasone acetate + melatonin - Drug Profile

EPO-Variant - Drug Profile

ESN-502 - Drug Profile

felbamate - Drug Profile

FIB-117 - Drug Profile

glyburide - Drug Profile

HBI-002 - Drug Profile

HBI-137 - Drug Profile

HBN-1 - Drug Profile

HBN-2 - Drug Profile

HPI-201 - Drug Profile

ibudilast - Drug Profile

ICCN-100 - Drug Profile

IRX-4204 - Drug Profile

ISC-hpNSC - Drug Profile

JM-4 - Drug Profile

KPT-350 - Drug Profile

LB-201 - Drug Profile

LB-205 - Drug Profile

LM11A-31 - Drug Profile

Lpathomab - Drug Profile

MAP-4343 - Drug Profile

MultiStem - Drug Profile

ND-478 - Drug Profile

NNI-370 - Drug Profile

NNZ-2591 - Drug Profile

NSI-189 - Drug Profile

NSI-566 - Drug Profile

NVP-019 - Drug Profile

NVX-428 - Drug Profile

NX-210 - Drug Profile

PGI-02776 - Drug Profile

Posiphen - Drug Profile

progesterone - Drug Profile

PRV-002 - Drug Profile

PYC-35 - Drug Profile

PYC-36 - Drug Profile

PYC-38 - Drug Profile

PYC-98 - Drug Profile

R-503 - Drug Profile

RAP-701 - Drug Profile

RGN-352 - Drug Profile

SB-623 - Drug Profile

sepranolone - Drug Profile

Small Molecule to Activate Epsilon PKC for Traumatic Brain Injury - Drug Profile

Small Molecule to Antagonize GPR17 for Central Nervous System Disorders - Drug Profile

Small Molecule to Inhibit Amyloid Beta Peptide for Traumatic Brain Injury and Alzheimer’s Disease - Drug Profile

Small Molecules for Stroke and Traumatic Brain Injury - Drug Profile

Small Molecules to Activate P2Y Receptor for Stroke and Traumatic Brain Injury - Drug Profile

Small Molecules to Agonize TrkB for Ophthalmology and Central Nervous System - Drug Profile

Small Molecules to Antagonize NMDA2A for Central Nervous System Disorders - Drug Profile

Small Molecules to Antagonize TLR-4 for CNS Disorders - Drug Profile

Small Molecules to Inhibit PBR for Traumatic Brain Injury and Neurodegenerative Diseases - Drug Profile

Stem Cell Therapy for CNS Disorders - Drug Profile

STSE-15 - Drug Profile

T-094 - Drug Profile

TBI-121 - Drug Profile

TBI-122 - Drug Profile

TBI-123 - Drug Profile

trofinetide - Drug Profile

UH-0113 - Drug Profile

UH-0213 - Drug Profile

VG-1177 - Drug Profile

VitalHeme - Drug Profile

VOLT-02 - Drug Profile

Traumatic Brain Injury - Recent Pipeline Updates

Traumatic Brain Injury - Dormant Projects

Traumatic Brain Injury - Discontinued Products

Traumatic Brain Injury - Product Development Milestones

Featured News & Press Releases

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Number of Products under Development for Traumatic Brain Injury, H2 2015

Number of Products under Development for Traumatic Brain Injury - Comparative Analysis, H2 2015

Number of Products under Development by Companies, H2 2015

Number of Products under Development by Companies, H2 2015 (Contd..1)

Number of Products under Development by Companies, H2 2015 (Contd..2)

Number of Products under Development by Companies, H2 2015 (Contd..3)

Number of Products under Investigation by Universities/Institutes, H2 2015

Comparative Analysis by Late Stage Development, H2 2015

Comparative Analysis by Clinical Stage Development, H2 2015

Comparative Analysis by Early Stage Development, H2 2015

Comparative Analysis by Unknown Stage Development, H2 2015

Products under Development by Companies, H2 2015

Products under Development by Companies, H2 2015 (Contd..1)

Products under Development by Companies, H2 2015 (Contd..2)

Products under Development by Companies, H2 2015 (Contd..3)

Products under Development by Companies, H2 2015 (Contd..4)

Products under Investigation by Universities/Institutes, H2 2015

Traumatic Brain Injury - Pipeline by Adamas Pharmaceuticals, Inc., H2 2015

Traumatic Brain Injury - Pipeline by ALSP, Inc., H2 2015

Traumatic Brain Injury - Pipeline by Amarantus Bioscience Holdings, Inc., H2 2015

Traumatic Brain Injury - Pipeline by Athersys, Inc., H2 2015

Traumatic Brain Injury - Pipeline by BHR Pharma, LLC, H2 2015

Traumatic Brain Injury - Pipeline by Cognosci, Inc., H2 2015

Traumatic Brain Injury - Pipeline by Euroscreen S.A., H2 2015

Traumatic Brain Injury - Pipeline by Grupo Ferrer Internacional, S.A., H2 2015

Traumatic Brain Injury - Pipeline by International Stem Cell Corporation, H2 2015

Traumatic Brain Injury - Pipeline by Io Therapeutics, Inc., H2 2015

Traumatic Brain Injury - Pipeline by Ischemix, H2 2015

Traumatic Brain Injury - Pipeline by Karyopharm Therapeutics, Inc., H2 2015

Traumatic Brain Injury - Pipeline by Kyorin Pharmaceutical Co., Ltd., H2 2015

Traumatic Brain Injury - Pipeline by Levolta Pharmaceuticals, Inc., H2 2015

Traumatic Brain Injury - Pipeline by Lixte Biotechnology Holdings, Inc., H2 2015

Traumatic Brain Injury - Pipeline by Lpath, Inc., H2 2015

Traumatic Brain Injury - Pipeline by MandalMed, Inc., H2 2015

Traumatic Brain Injury - Pipeline by Mapreg S.A.S., H2 2015

Traumatic Brain Injury - Pipeline by Mnemosyne Pharmaceuticals, Inc., H2 2015

Traumatic Brain Injury - Pipeline by Neuralstem, Inc., H2 2015

Traumatic Brain Injury - Pipeline by Neuren Pharmaceuticals Limited, H2 2015

Traumatic Brain Injury - Pipeline by NeuroHealing Pharmaceuticals Inc., H2 2015

Traumatic Brain Injury - Pipeline by NeuroNascent, Inc., H2 2015

Traumatic Brain Injury - Pipeline by Neuronax SAS, H2 2015

Traumatic Brain Injury - Pipeline by NeuroVive Pharmaceutical AB, H2 2015

Traumatic Brain Injury - Pipeline by Omeros Corporation, H2 2015

Traumatic Brain Injury - Pipeline by PharmatrophiX, Inc., H2 2015

Traumatic Brain Injury - Pipeline by Phylogica Limited, H2 2015

Traumatic Brain Injury - Pipeline by Prevacus, Inc., H2 2015

Traumatic Brain Injury - Pipeline by PsychoGenics, Inc., H2 2015

Traumatic Brain Injury - Pipeline by QR Pharma, Inc., H2 2015

Traumatic Brain Injury - Pipeline by RAPID Pharmaceuticals AG, H2 2015

Traumatic Brain Injury - Pipeline by RegeneRx Biopharmaceuticals, Inc., H2 2015

Traumatic Brain Injury - Pipeline by Remedy Pharmaceuticals, Inc., H2 2015

Traumatic Brain Injury - Pipeline by Sage Therapeutics, H2 2015

Traumatic Brain Injury - Pipeline by SanBio, Inc., H2 2015

Traumatic Brain Injury - Pipeline by STATegics, Inc., H2 2015

Traumatic Brain Injury - Pipeline by Tetra Discovery Partners LLC, H2 2015

Traumatic Brain Injury - Pipeline by VG Life Sciences, Inc., H2 2015

Assessment by Monotherapy Products, H2 2015

Assessment by Combination Products, H2 2015

Number of Products by Stage and Target, H2 2015

Number of Products by Stage and Mechanism of Action, H2 2015

Number of Products by Stage and Route of Administration, H2 2015

Number of Products by Stage and Molecule Type, H2 2015

Traumatic Brain Injury Therapeutics - Recent Pipeline Updates, H2 2015

Traumatic Brain Injury - Dormant Projects, H2 2015

Traumatic Brain Injury - Dormant Projects (Contd..1), H2 2015

Traumatic Brain Injury - Dormant Projects (Contd..2), H2 2015

Traumatic Brain Injury - Discontinued Products, H2 2015

List of Figures

Number of Products under Development for Traumatic Brain Injury, H2 2015

Number of Products under Development for Traumatic Brain Injury - Comparative Analysis, H2 2015

Number of Products under Development by Companies, H2 2015

Number of Products under Investigation by Universities/Institutes, H2 2015

Comparative Analysis by Clinical Stage Development, H2 2015

Comparative Analysis by Early Stage Products, H2 2015

Assessment by Monotherapy Products, H2 2015

Number of Products by Top 10 Targets, H2 2015

Number of Products by Stage and Top 10 Targets, H2 2015

Number of Products by Top 10 Mechanism of Actions, H2 2015

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015

Number of Products by Top 10 Routes of Administration, H2 2015

Number of Products by Stage and Top 10 Routes of Administration, H2 2015

Number of Products by Top 10 Molecule Types, H2 2015

Number of Products by Stage and Top 10 Molecule Types, H2 2015

Note: Product cover images may vary from those shown
3 of 4

Adamas Pharmaceuticals, Inc.
ALSP, Inc.
Amarantus Bioscience Holdings, Inc.
Athersys, Inc.
BHR Pharma, LLC
Cognosci, Inc.
Euroscreen S.A.
Grupo Ferrer Internacional, S.A.
International Stem Cell Corporation
Io Therapeutics, Inc.
Ischemix
Karyopharm Therapeutics, Inc.
Kyorin Pharmaceutical Co., Ltd.
Levolta Pharmaceuticals, Inc.
Lixte Biotechnology Holdings, Inc.
Lpath, Inc.
MandalMed, Inc.
Mapreg S.A.S.
Mnemosyne Pharmaceuticals, Inc.
Neuralstem, Inc.
Neuren Pharmaceuticals Limited
NeuroHealing Pharmaceuticals Inc.
NeuroNascent, Inc.
Neuronax SAS
NeuroVive Pharmaceutical AB
Omeros Corporation
PharmatrophiX, Inc.
Phylogica Limited
Prevacus, Inc.
PsychoGenics, Inc.
QR Pharma, Inc.
RAPID Pharmaceuticals AG
RegeneRx Biopharmaceuticals, Inc.
Remedy Pharmaceuticals, Inc.
Sage Therapeutics
SanBio, Inc.
STATegics, Inc.
Tetra Discovery Partners LLC

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Shire PLC.
  • GlaxoSmithKline PLC
  • Astrazeneca PLC
  • Roche Diagnostics Ltd.
  • H. Lundbeck A/S
  • Electrical Geodesics, Inc.